Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
A total of 17 labs will be operational across the country by this month
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
110 BDS graduates admitted in week one of the launch
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI)
The facility is spread across 215000 sq. feet and provides super-speciality care
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Subscribe To Our Newsletter & Stay Updated